Skip to main content
Veterinary Medicines

GALLIVAC IBD S706 – Vaccino liofilizzato, a virus vivi attenuati per polli

Authorised
  • Infectious bursal disease virus, strain S706, Live

Product identification

Medicine name:
GALLIVAC IBD S706 – Vaccino liofilizzato, a virus vivi attenuati per polli
Active substance:
  • Infectious bursal disease virus, strain S706, Live
Target species:
  • Chicken (broiler)
  • Chicken (pullet for egg production, future layer)
  • Chicken (pullet future breeder)
Route of administration:
  • Oculonasal use

Product details

Active substance and strength:
  • Infectious bursal disease virus, strain S706, Live
    4.00
    log10 50% cell culture infectious dose
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate for oculonasal suspension
Withdrawal period by route of administration:
  • Oculonasal use
    • Chicken (broiler)
      • Meat and offal
        0
        day
    • Chicken (pullet for egg production, future layer)
      • Egg
        0
        day
      • Meat and offal
        0
        day
    • Chicken (pullet future breeder)
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD09
Authorisation status:
  • Valid
Authorised in:
  • Italy
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Boehringer Ingelheim Animal Health Italia S.p.A. In Breve Boehringer Ingelheim Ah It S.p.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health Italia S.p.A. In Breve Boehringer Ingelheim Ah It S.p.A.
  • Boehringer Ingelheim Animal Health France
Responsible authority:
  • Ministry Of Health
Authorisation number:
This information is not available for this product.
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Italian (PDF)
Published on: 28/12/2023